Incidencia de riesgos biológicos mediante el método biogaval neo 2018 en laboratorios clínicos privados
Open Access
- 15 August 2023
- journal article
- research article
- Published by Fundacion Koinonia in Revista Arbitrada Interdisciplinaria de Ciencias de la Salud. Salud y Vida
- Vol. 7 (2) , 986-993
Abstract
Objective: to evaluate biological risks by applying the BIOGAVAL neo 2018 method in private clinical laboratories in Ambato - Ecuador. Method: Descriptive observational. Results and conclusions: From the BIOGAVAL method, in the private clinical laboratories of Ambato, where 4 biological agents were identified, having HIV with NAB of 9, Influenza virus with a NAB value of 8, SARS-CoV-2 virus with a NAB of 10, Staphylococcus Aureus with a NAB of 9, These are pathogens that produce serious diseases for humans, although it should be taken into account that none of them exceeds the biological exposure limit, so preventive actions should be improved to reduce the risk of biological exposure. Objetivo: evaluar los riesgos biológicos mediante la aplicación del método BIOGAVAL neo 2018 en los laboratorios clínicos privados de Ambato – Ecuador. Método: Descriptiva observacional. Resultados y conclusiones: A partir del método BIOGAVAL, en los laboratorios clínicos privados de Ambato, donde se identificaron 4 agentes biológicos, teniendo el VIH con NAB de 9, virus de Influenza con un valor de NAB de 8, virus de SARS-CoV-2 con un NAB de 10, Staphylococcus Aureus con un NAB de 9, por lo cual son patógenos que producen enfermedades graves para el ser humano, aunque hay que tomar en cuenta que ninguna sobrepasa el límite de exposición biológica, por lo cual se debe mejorar las acciones preventivas para disminuir su riesgo de exposición biológica.Keywords
This publication has 6 references indexed in Scilit:
- The Anatomic Pathology laboratory adjustments in the era of COVID-19 pandemic: The experience of a laboratory in a Portuguese central hospitalAnnals of Diagnostic Pathology, 2020
- Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global surveyClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce RecommendationsClinical Chemistry and Laboratory Medicine (CCLM), 2020
- The COVID-19 pandemic: implications for the cytology laboratoryJournal of the American Society of Cytopathology, 2020
- Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID‐19) infection: Perspectives from TaiwanCancer Cytopathology, 2020
- Influenza virus-related critical illness: pathophysiology and epidemiologyCritical Care, 2019